Rigosertib (ON-01910 sodium salt, with Estybon as trade name) is a synthetic benzyl styryl sulfone in development by Onconova Therapeutics. it has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma, and Neoplasms, among others. Reference standards of Rigosertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Rigosertib
Catalogue No.:PA 18 1190000
CAS :
Molecular Formula : C21H25NO8S
Molecular Weight : 451.49
2-((4-Methoxy-3-nitrobenzyl)thio)acetic Acid
Catalogue No.:PA 18 1191000
Molecular Formula : C10H11NO5S
Molecular Weight : 257.26
2-((4-Methoxy-3-nitrobenzyl)sulfinyl)acetic Acid
Catalogue No.:PA 18 1191001
Molecular Formula : C10H11NO6S
Molecular Weight : 273.26
1-Methoxy-4-((methylsulfonyl)methyl)-2-nitrobenzene
Catalogue No.:PA 18 1191002
Molecular Formula : C9H11NO5S
Molecular Weight : 245.25
2-Methoxy-5-((methylsulfonyl)methyl)aniline
Catalogue No.:PA 18 1191003
Molecular Formula : C9H13NO3S
Molecular Weight : 215.27
(E)-2-Methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)aniline
Catalogue No.:PA 18 1191004
Molecular Formula : C19H23NO6S
Molecular Weight : 393.45
2-Methoxy-5-(((2,4,6-trimethoxyphenethyl)sulfonyl)methyl)aniline
Catalogue No.:PA 18 1191005
Molecular Formula : C19H25NO6S
Molecular Weight : 395.47
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
